Capricor Therapeutics, Inc. (CAPR)
9.40
+0.12
(+1.29%)
USD |
NASDAQ |
Sep 04, 16:00
9.40
0.00 (0.00%)
After-Hours: 20:00
Capricor Therapeutics SG&A Expense (TTM) : 35.43M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.43M |
| March 31, 2026 | 27.02M |
| December 31, 2025 | 23.69M |
| September 30, 2025 | 21.94M |
| June 30, 2025 | 19.48M |
| March 31, 2025 | 16.86M |
| December 31, 2024 | 14.87M |
| September 30, 2024 | 13.80M |
| June 30, 2024 | 13.36M |
| March 31, 2024 | 13.15M |
| December 31, 2023 | 12.59M |
| September 30, 2023 | 12.17M |
| June 30, 2023 | 11.72M |
| March 31, 2023 | 11.23M |
| December 31, 2022 | 10.43M |
| September 30, 2022 | 9.754M |
| June 30, 2022 | 8.989M |
| March 31, 2022 | 8.422M |
| December 31, 2021 | 7.612M |
| September 30, 2021 | 6.990M |
| June 30, 2021 | 6.490M |
| March 31, 2021 | 6.311M |
| December 31, 2020 | 5.543M |
| September 30, 2020 | 4.927M |
| June 30, 2020 | 4.537M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.759M |
| December 31, 2019 | 3.605M |
| September 30, 2019 | 3.840M |
| June 30, 2019 | 4.195M |
| March 31, 2019 | 4.548M |
| December 31, 2018 | 4.962M |
| September 30, 2018 | 5.095M |
| June 30, 2018 | 4.924M |
| March 31, 2018 | 4.993M |
| December 31, 2017 | 4.793M |
| September 30, 2017 | 4.702M |
| June 30, 2017 | 4.865M |
| March 31, 2017 | 5.045M |
| December 31, 2016 | 4.933M |
| September 30, 2016 | 4.856M |
| June 30, 2016 | 4.569M |
| March 31, 2016 | 4.061M |
| December 31, 2015 | 4.372M |
| September 30, 2015 | 3.979M |
| June 30, 2015 | 3.826M |
| March 31, 2015 | 3.566M |
| December 31, 2014 | 3.022M |
| September 30, 2014 | 3.638M |
| June 30, 2014 | 3.080M |
| March 31, 2014 | 2.799M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 85.56M |
| Cytokinetics, Inc. | 370.47M |
| Emergent BioSolutions, Inc. | 181.20M |
| Rigel Pharmaceuticals, Inc. | 122.22M |
| United Therapeutics Corp. | 644.60M |